Adalimumab: A Review in Chronic Plaque Psoriasis-Reference-Cited by-同舟云学术

Adalimumab: A Review in Chronic Plaque Psoriasis

Published:2015-11-19 Issue:18 Volume:75 Page:2119-2130
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Burness Celeste B.,McKeage Kate

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-015-0503-x.pdf

Reference75 articles.

1. National Psoriasis Foundation. Psoriasis overview and psoriasis statistics. 2015. https://www.psoriasis.org/ . Accessed 15 Oct 2015.

2. Bronckers IM, Paller AS, van Geel MJ, et al. Psoriasis in children and adolescents: diagnosis, management and comorbidities. Paediatr Drugs. 2015;17(5):373–84.

3. Boehncke WH, Schon MP. Psoriasis. Lancet. 2015;386(9997):983–94.

4. NICE. Psoriasis: the assessment and management of psoriasis (NICE guidelines [CG153]). 2012. http://www.nice.org.uk/guidance/cg153 . Accessed 15 Oct 2015.

5. European Dermatology Forum (EDF). European S3-guidelines on the systemic treatment of psoriasis vulgaris: update 2015. 2015. http://www.euroderm.org/edf/ . Accessed 13 Oct 2015.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets;Frontiers in Immunology;2024-01-04

2. Current and emerging prospects in the psoriatic treatment;International Immunopharmacology;2023-07

3. Biologics in pediatric psoriasis;The Journal of Dermatology;2023-01-18

4. Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial;British Journal of Dermatology;2023-01

5. Annoying Psoriasis and Atopic Dermatitis: A Narrative Review;International Journal of Molecular Sciences;2022-04-28